Recognition and management of depression in a substance use disorder treatment population.
This study examines the association between depressive symptomatology and return to substance use among a sample of 126 veterans consecutively admitted to treatment at a VA intensive outpatient program for substance use disorders. Controlling for numerous demographic and health-related covariates, depressive symptomatology measured at treatment exit with a Beck Depression Inventory (BDI) was significantly predictive of substance use at three-months post-treatment (p < .05). Analysis with a recoded BDI showed that the moderately-to-severely symptomatic (BDI = 20+) were 4.1 times more likely to have returned to substance use than those with a BDI score of under 20.
Curran
G M
GM
VA HSR&D Center for Mental Healthcare and Outcome Research, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72114, USA. currangeoffrevm@uams.edu
Booth
B M
BM
Kirchner
J E
JE
Deneke
D E
DE
D000328:Adult; D000553:Ambulatory Care; D000928:Antidepressive Agents / Q000627:therapeutic use; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D008297:Male; D010555:Personality Inventory / Q000706:statistics & numerical data; D011379:Prognosis; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011594:Psychometrics; D055502:Secondary Prevention; D012720:Severity of Illness Index; D016320:Substance Abuse Treatment Centers / Q000379:methods*; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation / Q000628:therapy*; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014493:United States Department of Veterans Affairs
D000928:Antidepressive Agents